Katie is an experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.
Katie works with clients to represent their needs before the US Congress and the US Department of Health and Human Services (HHS) and its agencies by relying on extensive experience as a policy advisor on the Medicaid and Medicare programs, as well as the 340B program and other aspects of the Public Health Service Act. She anticipates the effects of state and federal policymaking on issues impacting their businesses and crafts proactive and comprehensive legislative strategies.
Katie served as a senior analyst at the Medicaid and CHIP Payment and Access Commission (MACPAC), where she developed policy recommendations and conducted legislative analyses related to Medicare and Medicaid issues in support of Congress and HHS. At MACPAC, Katie regularly interpreted and analyzed large data sets for reports.
Prior to her work with MACPAC, Katie served in Senator Chuck Grassley’s (R-IA) office as a health policy fellow where she conducted research and analyses on health policy options. She also worked at George Washington University, where she led the Teaching Health Center Graduate Medical Education evaluation.
George Washington University, M.P.H.
Boston University, B.S.
Pharmacy Benefit Manager Reform: What’s on the Horizon?
CMS Releases FY 2024 IPPS Final Rule
CMS Releases Proposed Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018–2022
CMS Releases Proposed Rule: Medicaid and CHIP Managed Care Access, Finance, and ...
CMS Releases Proposed Rule: Medicaid Program; Ensuring Access to Medicaid Services
CMS Releases FY 2024 IPPS Proposed Update
President’s FY 2024 Budget: HHS Highlights
Proposed Changes to DSH Payment Calculation Regulations Could Impact 340B Hospitals
Consolidated Appropriations Act, 2023: Health Provisions
Way Too Early Preview: What the Midterm Election Results Might Mean for ...
Post-Election Committee Membership Tracker
The Inflation Reduction Act of 2022: Healthcare Provisions Updated: 08/16/2022
CMS Releases FY 2023 IPPS Final Rule
CMS Releases FY 2023 IPPS Proposed Update
President’s FY 2023 Budget: HHS Highlights
Interim Final Rule with comment (IFR) to Surprise Billing; Part II
Health Policy Breakroom - Ep 75 No Surprises Billing Act 1 day ago1 day ...
Requirements Related to Surprise Billing; Part I: Policy Update
President’s Fiscal Year 2022 Budget: What You Need to Know
Health Policy Breakroom Ep. 66 - The American Families Plan
Health Policy Breakroom Ep. 65 - CMS Reverses Texas Medicaid Waiver
2021 Legislative Calendar (Updated March 2021)
American Rescue Plan Act of 2021: Key Healthcare Provisions
Health Policy Breakroom Ep. 60 - The American Rescue Plan
117th Congress: Leadership and Health Committee Membership
Health Policy Breakroom Ep. 56 - Surprise Billing in the Consolidated Appropriations Act
Surprise Billing in the Consolidated Appropriations Act, 2021: Details and Analysis of Process
The First 100 Days: Biden's Healthcare Outlook
Summary of Key Health Provisions in the Consolidated Appropriations Act, 2021
Drug Pricing – Trump Administration Announces Most-Favored Nation Drug Pricing Model
Show MoreDo not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
